Related Experiment Videos
Cholesterol reduction and life expectancy. A model incorporating multiple risk factors
Annals of Internal Medicine
|April 1, 1987
Summary
Dietary changes to lower cholesterol may offer modest life expectancy gains, ranging from days to 12 months. This information helps individuals decide on cholesterol-lowering diets for better heart health.
Area of Science:
- Cardiovascular Health
- Preventive Medicine
- Biostatistics
Background:
- Elevated serum cholesterol is a significant risk factor for ischemic heart disease mortality.
- Informed decision-making regarding dietary interventions requires quantifying potential health benefits.
Purpose of the Study:
- To model the potential gain in life expectancy from lifelong cholesterol reduction.
- To assess the impact of dietary changes on ischemic heart disease risk.
Main Methods:
- Developed a predictive model for life expectancy gains.
- Considered asymptomatic adults aged 20-60 with total serum cholesterol 180-300 mg/dL.
- Risk stratification based on blood pressure, smoking, and HDL cholesterol levels.
Main Results:
- Low-risk individuals: 3 days to 3 months gain in life expectancy.
- High-risk individuals: 18 days to 12 months gain in life expectancy.
- Benefits are calculated for a lifelong cholesterol reduction program.
Conclusions:
- Dietary cholesterol reduction can lead to measurable increases in life expectancy.
- Quantified benefits can aid individuals in making informed decisions about dietary changes.
- The model provides a framework for understanding the long-term impact of cholesterol management.
Related Concept Videos
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lifestyle Factors and Health
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...